Clinical Trial Update: Phase Ib/IIa Trial With AC01 in Patients With HFrEF [Phase 1, Phase 2]

View source ↗

Summary

The document reports the completion of a Phase Ib/IIa trial of AC01 in patients with heart failure with reduced ejection fraction (HFrEF) conducted by AnaCardio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• AC01

Snippet

Sponsor: AnaCardio AB | Conditions: Heart Failure With Reduced Ejection Fraction | Phase 1, Phase 2 | Status: COMPLETED